Renal cell carcinoma and Hyperlipidaemia

Summary:

Hyperlipidaemia is found among people with Renal cell carcinoma, especially for people who are male, 60+ old.

The study analyzes which people have Hyperlipidaemia with Renal cell carcinoma. It is created by eHealthMe based on reports of 46 people who have Renal cell carcinoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Renal cell carcinoma?

Renal cell carcinoma (a kidney cancer) is found to be associated with 787 drugs and 1,339 conditions by eHealthMe. Check the latest studies of Renal cell carcinoma.

What is Hyperlipidaemia?

Hyperlipidaemia (presence of excess lipids in the blood) is found to be associated with 1,423 drugs and 1,410 conditions by eHealthMe. Check the latest studies of Hyperlipidaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

46 people who have Renal Cell Carcinoma and Hyperlipidaemia are studied.

Would you have Hyperlipidaemia when you have Renal cell carcinoma?

Gender of people who have Renal Cell Carcinoma and experienced Hyperlipidaemia *:

female: 24.44 %
male: 75.56 %

Age of people who have Renal Cell Carcinoma and experienced Hyperlipidaemia *:

Common co-existing conditions for these people *:

Pain: 4 people, 8.70%
Metastases To Bone (cancer spreads to bone): 3 people, 6.52%
Osteoporosis (bones weak and more likely to break): 3 people, 6.52%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 2.17%
Chest Pain: 1 person, 2.17%
Constipation: 1 person, 2.17%
Diabetes: 1 person, 2.17%
Dry Eyes (lack of adequate tears): 1 person, 2.17%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 2.17%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 1 person, 2.17%

Common drugs taken by these people *:

Common symptoms for these people *:

High Blood Pressure: 21 people, 45.65%
Diarrhea: 13 people, 28.26%
Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 12 people, 26.09%
Thrombocytopenia (decrease of platelets in blood): 12 people, 26.09%
Fatigue (feeling of tiredness): 11 people, 23.91%
Anaemia (lack of blood): 11 people, 23.91%
Hyperkalemia (damage to or disease of the kidney): 8 people, 17.39%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 8 people, 17.39%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 15.22%
Dizziness: 7 people, 15.22%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hyperlipidaemia?

- Check whether Hyperlipidaemia is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Renal cell carcinoma (141,599 reports)
Hyperlipidaemia (86,394 reports)

All the drugs that are associated with Hyperlipidaemia:

Hyperlipidaemia (1,423 drugs)

All the conditions that are associated with Hyperlipidaemia:

Hyperlipidaemia (1,410 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hyperlipidaemia and Renal cell carcinoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.